Collegium Pharmaceutical reported that its free cash flow declined over the last year, while a negative accrual ratio indicated FCF exceeded statutory profit.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Collegium Pharmaceutical reported that its free cash flow declined over the last year, while a negative accrual ratio indicated FCF exceeded statutory profit.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Collegium Pharmaceutical (United States)
company in Dedham, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.We Think You Can Look Beyond Collegium Pharmaceutical's (NASDAQ:COLL) Lackluster Earnings Explore Collegium Pharmaceutical's Fair Values from the Community and select yours Collegium Pharmaceutical,